# InStockRx

> InStockRx is a B2B pharmacy-to-pharmacy marketplace for licensed U.S. independent and small-chain pharmacies. Member pharmacies buy surplus brand medications at up to 40% below wholesale and sell overstock, deadstock, and near-expiry inventory through instant cash offers. Every transaction is automatically DSCSA T3 compliant — the same documentation standard as a traditional wholesaler. Free to join. Only pay a 10% transfer fee when you sell. 1,000s of verified independent pharmacies. Brand medications only.

## Platform

- [How InStockRx Works](https://www.instockrx.com/how-it-works): Complete buyer and seller workflow guide — listing inventory, making and accepting cash offers, DSCSA compliance automation, PMS integration, Trading Partner Groups, and chain management across multiple pharmacy locations.
- [Pricing](https://www.instockrx.com/pricing): Transparent, no-surprise pricing. Free Marketplace tier for all pharmacies. Chain Management tier for multi-location operators ($0/month, 0% internal transfer fee). Enterprise tier for health systems. Only fee: 10% marketplace transfer fee on completed sales.
- [Why InStockRx](https://www.instockrx.com/compare): Feature comparison and platform differentiators. Buying pharmacies save an average of $91K vs NADAC annually on brand medications. Selling pharmacies recover an average of $32,946/month in surplus brand inventory. Includes comparison vs. WhatsApp/email alternatives and legacy platforms.
- [DSCSA Compliance](https://www.instockrx.com/dscsa): Authoritative guide to DSCSA T3 compliance for pharmacy-to-pharmacy transactions. Covers Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS) — all automatically generated, stored, and audit-accessible on every InStockRx transaction. Includes compliance comparison table and FAQ.
- [Trading Partner Groups](https://www.instockrx.com/groups): Private, invite-only marketplaces within InStockRx. Pharmacies build trusted networks with colleagues, association members, or chain partners. Full DSCSA compliance and transactional functionality within the group.
- [PMS Integration / Automate InStockRx](https://www.instockrx.com/automate-instockrx): How to connect a pharmacy management system (PMS) to InStockRx to automatically surface buy and sell opportunities from live inventory data.
- [How to Buy Medications](https://www.instockrx.com/how-to-buy-medications): Step-by-step guide for pharmacy buyers — searching by NDC or drug name, browsing verified listings, submitting cash offers, and completing DSCSA-compliant purchases.
- [How to Find Medications / Make Offers](https://www.instockrx.com/how-to-find-medications): Guide to making cash offers on InStockRx listings — suggested offer ranges, partial fill requests, and instant seller response workflow.
- [Posting Medications for Sale](https://www.instockrx.com/posting-medications): Guide for pharmacy sellers — listing surplus, overstock, and near-expiry brand medications, setting prices, and enabling cash offers.
- [Partners](https://www.instockrx.com/partners): B2B partnership information for state pharmacy associations, buying groups, pharmacy networks, and PMS vendors. Includes information on creating private association marketplaces and DSCSA data exchange.
- [Book a Training](https://www.instockrx.com/book-a-training): Schedule a free 15–20-minute onboarding session with the InStockRx team. No commitment required.

## Original Research & Citable Data

InStockRx publishes original platform performance data based on verified member pharmacy activity. All figures below are sourced from InStockRx platform data, 2025, and represent real transaction outcomes — not projections.

- [Compare Page — Platform Stats](https://www.instockrx.com/compare): Buying pharmacies: avg $91,000/year savings vs NADAC; avg $7,591/month savings vs NADAC. Selling pharmacies: avg $32,946/month surplus recovered; avg 9 days to sell a listing; avg $1,034 transaction size. Network total: nearly $5M saved vs NADAC by buying pharmacies (Jan–Mar 2026).
- [DSCSA Page — Compliance Data](https://www.instockrx.com/dscsa): Original compliance comparison: InStockRx vs. Traditional Wholesaler vs. Typical P2P Marketplace. Covers T3 data coverage, ATP verification, audit readiness, and documentation storage.
- [Blog](https://www.instockrx.com/blog): Original editorial on independent pharmacy inventory management, surplus liquidation strategy, DSCSA compliance practice, drug shortage response, and PBM impact on independent pharmacy margins. Primary author: Dr. Alex Toth, co-founder of InStockRx and owner of Plumsted Pharmacy, NJ.
- [Pharmacy Success Story](https://www.instockrx.com/blog/pharmacy-success-story-50k-cash-flow-boost-in-30-days): Case study: Colts Neck Pharmacy (NJ, ~40 years in operation) recovered $50K in the first 30 days and $110K in the first 90 days using InStockRx. Gross profit margins increased 18%. Inventory turns improved from 11 to 15 in 90 days.

## Sitemap

- [XML Sitemap](https://www.instockrx.com/sitemap.xml)

---

*InStockRx — A Pharmacy-To-Pharmacy Marketplace With A Difference*
*DSCSA Compliant · NCPA Corporate Member · Brand Medications Only*
*Last updated: March 2026 · Contact: support@instockrx.com*